These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 37861027)
1. A Review of Proposed Mechanisms in Rheumatoid Arthritis and Therapeutic Strategies for the Disease. Mohite R; Doshi G Endocr Metab Immune Disord Drug Targets; 2024; 24(3):291-301. PubMed ID: 37861027 [TBL] [Abstract][Full Text] [Related]
2. PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes. Kwon EJ; Park EJ; Choi S; Kim SR; Cho M; Kim J Int J Rheum Dis; 2017 Oct; 20(10):1499-1509. PubMed ID: 27456070 [TBL] [Abstract][Full Text] [Related]
3. Editorial: Immunomodulatory Functions of Fibroblast-like Synoviocytes in Joint Inflammation and Destruction during Rheumatoid Arthritis. Xu H; Zheng SG; Fox D Front Immunol; 2020; 11():955. PubMed ID: 32508834 [No Abstract] [Full Text] [Related]
4. 1, 25-dihydroxy-vitamin D3 with tumor necrosis factor-alpha protects against rheumatoid arthritis by promoting p53 acetylation-mediated apoptosis via Sirt1 in synoviocytes. Gu X; Gu B; Lv X; Yu Z; Wang R; Zhou X; Qiao W; Mao Z; Zuo G; Li Q; Miao D; Jin J Cell Death Dis; 2016 Oct; 7(10):e2423. PubMed ID: 27763638 [TBL] [Abstract][Full Text] [Related]
5. NR1D1 modulates synovial inflammation and bone destruction in rheumatoid arthritis. Liu H; Zhu Y; Gao Y; Qi D; Zhao L; Zhao L; Liu C; Tao T; Zhou C; Sun X; Guo F; Xiao J Cell Death Dis; 2020 Feb; 11(2):129. PubMed ID: 32071294 [TBL] [Abstract][Full Text] [Related]
6. The p53 status in rheumatoid arthritis with focus on fibroblast-like synoviocytes. Taghadosi M; Adib M; Jamshidi A; Mahmoudi M; Farhadi E Immunol Res; 2021 Jun; 69(3):225-238. PubMed ID: 33983569 [TBL] [Abstract][Full Text] [Related]
7. Cyanidin prevents the hyperproliferative potential of fibroblast-like synoviocytes and disease progression via targeting IL-17A cytokine signalling in rheumatoid arthritis. Samarpita S; Ganesan R; Rasool M Toxicol Appl Pharmacol; 2020 Mar; 391():114917. PubMed ID: 32044269 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic effects of matrine derivate MASM in mice with collagen-induced arthritis and on fibroblast-like synoviocytes. Zou Y; Li Q; Liu D; Li J; Cai Q; Li C; Zhao Q; Xu W Sci Rep; 2017 May; 7(1):2454. PubMed ID: 28550307 [TBL] [Abstract][Full Text] [Related]
9. Interleukin-36 family dysregulation drives joint inflammation and therapy response in psoriatic arthritis. Boutet MA; Nerviani A; Lliso-Ribera G; Lucchesi D; Prediletto E; Ghirardi GM; Goldmann K; Lewis M; Pitzalis C Rheumatology (Oxford); 2020 Apr; 59(4):828-838. PubMed ID: 31504934 [TBL] [Abstract][Full Text] [Related]
10. Kirenol Inhibits the Function and Inflammation of Fibroblast-like Synoviocytes in Rheumatoid Arthritis Wu J; Li Q; Jin L; Qu Y; Liang BB; Zhu XT; Du HY; Jie LG; Yu QH Front Immunol; 2019; 10():1304. PubMed ID: 31244849 [TBL] [Abstract][Full Text] [Related]
11. New potential therapeutic approaches targeting synovial fibroblasts in rheumatoid arthritis. José Alcaraz M Biochem Pharmacol; 2021 Dec; 194():114815. PubMed ID: 34715065 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-17-5p Reduces Inflammation and Bone Erosions in Mice With Collagen-Induced Arthritis and Directly Targets the JAK/STAT Pathway in Rheumatoid Arthritis Fibroblast-like Synoviocytes. Najm A; Masson FM; Preuss P; Georges S; Ory B; Quillard T; Sood S; Goodyear CS; Veale DJ; Fearon U; Le Goff B; Blanchard F Arthritis Rheumatol; 2020 Dec; 72(12):2030-2039. PubMed ID: 32683798 [TBL] [Abstract][Full Text] [Related]
13. Phlorizin Regulates Synovial Hyperplasia and Inflammation in Rats With Rheumatoid Arthritis by Regulating the mTOR Pathway. Wang L; Wu X; Wan Q; Yang Y; Gao C In Vivo; 2024; 38(3):1182-1191. PubMed ID: 38688626 [TBL] [Abstract][Full Text] [Related]
14. Self-actuating inflammation responsive hydrogel microsphere formulation for controlled drug release in rheumatoid arthritis (RA): Animal trials and study in human fibroblast like synoviocytes (hFLS) of RA patients. Singh R; Jadhav K; Kamboj R; Malhotra H; Ray E; Jhilta A; Dhir V; Verma RK Biomater Adv; 2024 Jun; 160():213853. PubMed ID: 38636119 [TBL] [Abstract][Full Text] [Related]
15. PPAR-γ alleviates the inflammatory response in TNF-α-induced fibroblast-like synoviocytes by binding to p53 in rheumatoid arthritis. Li XF; Yin SQ; Li H; Yang YL; Chen X; Song B; Wu S; Wu YY; Wang H; Li J Acta Pharmacol Sin; 2023 Feb; 44(2):454-464. PubMed ID: 35918412 [TBL] [Abstract][Full Text] [Related]
16. Leonurine attenuates fibroblast-like synoviocyte-mediated synovial inflammation and joint destruction in rheumatoid arthritis. Li N; Xu Q; Liu Q; Pan D; Jiang Y; Liu M; Liu M; Xu H; Lin C Rheumatology (Oxford); 2017 Aug; 56(8):1417-1427. PubMed ID: 28431044 [TBL] [Abstract][Full Text] [Related]
17. GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis. Jia W; Wu W; Yang D; Xiao C; Huang M; Long F; Su Z; Qin M; Liu X; Zhu YZ Cell Death Dis; 2018 May; 9(5):503. PubMed ID: 29717129 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis. Zou Y; Zeng S; Huang M; Qiu Q; Xiao Y; Shi M; Zhan Z; Liang L; Yang X; Xu H Br J Pharmacol; 2017 May; 174(9):893-908. PubMed ID: 28239846 [TBL] [Abstract][Full Text] [Related]